Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: J Prosthodont. 2012 Oct 25;22(1):13–22. doi: 10.1111/j.1532-849X.2012.00906.x

Table 4.

Prevalence of detectable C. Albicans and non-albicans in saliva, denture, and mucosal surfaces for control and DS participants. The table indicates the number of patients positive for Candida [albicans and non-albicans] and the percent positive within the disease category. The p-values are chi-square statistics between the control and the DS groups.

Saliva (N = 32) Denture (N = 32) Unaffected mucosa (N = 32) Affected mucosa (N = 15)
C. albicans Non-albicans C. albicans Non-albicans C. albicans Non-albicans C. albicans Non-albicans
Control (N = 17) 7 (41.2%) 7 (41.2%) 2 (11.8%) 8 (47.1%) 1 (5.9%) 7 (41.18%)
DS type II (N = 8) 7 (87.5%) 0 (0.00) 6 (75.0%) 0 (0.00%) 2 (25.0%) 2 (25.0%) 2 (25.0%) 3 (37.5%)
DS type III (N = 7) 5 (71.4%) 0 (0.00) 5 (71.4%) 2 (28.6%) 2 (28.6%) 4 (57.1%) 4 (57.1%) 3 (42.9%)
Total (N,%) 19 (59.4%) 7 (21.9%) 13 (40.6%) 10 (31.3%) 5 (15.6%) 13 (40.6%) 6 (40.0%) 6 (40.0%)
P values 0.03* 0.02* 0.002* 0.06* 0.27 0.45 0.20 0.83
*

Statistically significant (P < 0.05)